The influence of combined oral contraceptives on female sexual desire: A systematic review

REFERENCES

• Bitzer J, Simon JA. Current issues and available options in combined hormonal contraception. Contraception 2011;84:342–56.
   PubMed Web of Science ®Google Scholar
• Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: A review of the literature. Eur J Contracept Reprod Health Care 2010;15:4–16.
   PubMed Web of Science ®Google Scholar
• Brotto LA. Current literature review – editorial comment. J Sex Med 2011;8:3257.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington: American Psychiatric Press 2000.
   Google Scholar
• Basson R, Leiblum S, Brotto L, . Definitions of women's sexual dysfunction reconsidered: Advocating expansion and revision. J Psychosom Obstet Gynaecol 2003;24:221–9.
   PubMed Web of Science ®Google Scholar
• Davis AR, Castano PM. Oral contraceptives and sexuality. In Goldstein I, Meston C, Davis S, Traish A, eds. Women's sexual function & dysfunction – Study, diagnosis and treatment. London: Taylor & Francis 2006: 290–6.
   Google Scholar
• Guay AT, Spark R. Pathophysiology of sex steroids in women. In Goldstein I, Meston C, Davis S, Traish A, eds. Women's sexual function & dysfunction – Study, diagnosis and treatment. London: Taylor & Francis 2006: 218–28.
   Google Scholar
• Rabe T, Kowald A, Ortman J, Rehberger-Schneider S. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro. Gynecol Endocrinol 2000;14: 223–30.
   PubMed Web of Science ®Google Scholar
• Traish AM, Kim NN. Modulation of female genital sexual arousal by sex steroid hormones. In Goldstein I, Meston C, Davis S, Traish A, eds. Women's sexual function & dysfunction – Study, diagnosis and treatment. London: Taylor & Francis 2006:181–93.
   Google Scholar
• Warnock JK, Clayton A, Croft H, . Comparison of androgens in women with hypoactive sexual desire disorder: Those on combined oral contraceptives (COCs) vs. those not on COCs. J Sex Med 2006;3:878–82.
   PubMed Web of Science ®Google Scholar
• Bitzer J. Contraception and sexuality. Ther Umsch 1994;51:110–4.
   PubMedGoogle Scholar
• McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav 1996;25:73–90.
   PubMed Web of Science ®Google Scholar
• Graham CA, Ramos R, Bancroft J, . The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995;52:363–9.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Loftus J, Long JS. Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav 2003;32:193–208.
   PubMed Web of Science ®Google Scholar
• Bancroft J. Androgens and sexual function in men and women. In Bagatell CJ, Bremmer WJ, eds. Androgens in health and disease. Totowa, NJ: Humana Press 2003: 258–90.
   Google Scholar
• Bell RJ, Donath S, Davison, SL, Davis, SR. Endogenous androgen levels and wellbeing: differences between pre- and postmenopausal women. Menopause 2006;13:65–71.
   PubMed Web of Science ®Google Scholar
• Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6.
   PubMed Web of Science ®Google Scholar
• Guay A, Jacobson J, Munarriz R, . Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res 2004; 16:121–9.
   PubMed Web of Science ®Google Scholar
• Adams DB, Gold AR, Burt AD. Rise in female initiated sexual activity at ovulation and its suppression by oral contraceptives. N Engl J Med 1978;299:1145–50.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Tschudin S, Meier-Burgoa J, . Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin). Praxis 2003;92: 1177–84.
   PubMedGoogle Scholar
• Caruso S, Agnello C, Intelisano G, . Sexual behavior of women taking low-dose contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception 2004;69:237–40.
   PubMed Web of Science ®Google Scholar
• Panzer C, Wise S, Fantini G, . Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: A retrospective study in women with sexual dysfunction. J Sex Med 2006;3:104–13.
   PubMed Web of Science ®Google Scholar
• Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001;64:51–8.
   PubMed Web of Science ®Google Scholar
• Wallwiener CW, Wallwiener LM, Seeger H, . Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med 2010;7:2139–48.
   PubMed Web of Science ®Google Scholar
• Alexander GM, Sherwin BB, Bancroft J, Davidson, DW. Testosterone and sexual behavior in oral contraceptive users and non-users: A prospective study. Horm Beh 1990;24:388–402.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Intelisano G, . Prospective study on sexual behavior of women using 30 μg ethinylestradiol and 3 mg drospirenone oral contraceptive. Contraception 2005;72:19–23.
   PubMed Web of Science ®Google Scholar
• Caruso S, Iraci Sareri M, Agnello C, . Conventional versus extended-cycle oral contraceptives on the quality of sexual life: Comparison between two regimens containing 3 mg drospirenone and 20 μg ethinyl estradiol. J Sex Med 2011;8:1478–85.
   PubMed Web of Science ®Google Scholar
• Davis AR, Castano PM. Oral contraceptives and libido in women. Annu Rev Sex Res 2004;15:297–320.
   PubMedGoogle Scholar
• Gallo MF, Grimas DA, Schulz KF, Helmehorst FM. Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol 2004;103:359–73.
   PubMed Web of Science ®Google Scholar
• Gracia CR, Sammel MD, Charlesworth S, . Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril 2010;93:21–8.
   PubMed Web of Science ®Google Scholar
• Guida M, Di Spiezio Sardo A, Bramante S, . Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005;20:1100–6.
   PubMed Web of Science ®Google Scholar
• Li RH, Lo SS, Teh DK, . Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception 2004;70:474–82.
   PubMed Web of Science ®Google Scholar
• Redmond G, Godwin AJ, Olson W, Lippman JS. Use of placebo controls in an oral contraceptive trial: Methodological issues and adverse event incidence. Contraception 1999;60:81–5.
   PubMed Web of Science ®Google Scholar
• Schaffir J. Hormonal contraception and sexual desire: A critical review. J Sex Marital Ther 2006;32:305–14.
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1–20.
   PubMed Web of Science ®Google Scholar
• Rycroft-Malone J, McCormack B, Hutchinson AM, . Realist synthesis: illustrating the method for implementation research. Implementation Sci 2012;7:33. doi:10. 1186/1748-5908-7-33.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Davidson DW, Warner P, Tyrer G. Androgens and sexual behaviour in women using oral contraceptives. Clin Endocrinol 1980;12:327–40.
   PubMed Web of Science ®Google Scholar
• Graham CA, Sherwin BB. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual syndromes. Psychoneuroendocrinology 1993;18:273–81.
   PubMed Web of Science ®Google Scholar
• Alexander GM, Sherwin BB. Sex steroids, sexual behavior, and selection attention for erotic stimuli in women using oral contraceptives. Psychoneuroendocrinology 1993; 18:91–102.
   PubMed Web of Science ®Google Scholar
• Oranratanaphan S, Taneepanichskul S. A double blind randomized control trial comparing effect of drospirenone and gestodene to sexual desire and libido. J Med Assoc Thai 2006;89:S17–22.
   Google Scholar
• Graham CA, Bancroft J, Doll HA, . Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?Psychoneuroendocrinology 2007;32:246–55.
   PubMed Web of Science ®Google Scholar
• Greco T, Graham CA, Bancroft J, . The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol. Contraception 2007;76:8–17.
   PubMed Web of Science ®Google Scholar
• Caruso S, Rugolo S, Agnello C, . Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med 2009;6:3376–84.
   PubMed Web of Science ®Google Scholar
• Lee M, Morgan M, Rapkin A. Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: A preliminary study. J Sex Med 2011;8:213–8.
   PubMed Web of Science ®Google Scholar
• Strufaldi R, Pompei LM, Steiner ML, . Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels. Contraception 2010; 82:147–54.
   PubMed Web of Science ®Google Scholar
• Heiman JR, Rupp H, Janssen E, . Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Horm Behav 2011;59:772–9.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Romano M, . Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med 2011;8:2841–50.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Battaglia B, Mancini F, . Sexual behaviour and oral contraception: Pilot study. J Sex Med 2012; 9:550–7.
   PubMed Web of Science ®Google Scholar
• Fucs GB, Coutinho EM. Treatment of diminished sexual response associated with the use of oral contraceptives. Reproduccion 1975;2:97–104.
   PubMedGoogle Scholar
• Gambrell RD Jr, Bernard DM, Sanders BI, . Changes in sexual drives of patients on oral contraceptives. J Reprod Med 1976;17:165–71.
   PubMed Web of Science ®Google Scholar
• Erkkola R, Hirvonen E, Luikku J, . Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms. Acta Obstet Gynecol Scand 1990;1:61–5.
   Google Scholar
• Bancroft J, Sherwin BB, Alexander GM, . Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens. Arch Sex Behav 1991;20:121–35.
   PubMed Web of Science ®Google Scholar
• Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006;74:220–23.
   PubMed Web of Science ®Google Scholar
• Skrzypulec V, Drosdzol A. Evaluation of the quality of life and sexual functioning of women using a 30-μg ethinylestradiol and 3-mg drospirenone combined oral contraceptives. Eur J Contracept Reproduct Health Care 2008;13:49–57.
   PubMed Web of Science ®Google Scholar
• Warner P, Bancroft J. Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res 1988;32:417–27.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches M, Ortí RM, Monfort, M, . A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices. Eur J Contracept Reprod Health Care 2003;8:129–34.
   PubMed Web of Science ®Google Scholar
• Brucker C, Hedon B, The HS, . Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen. Contraception 2010;81:501–9.
   PubMed Web of Science ®Google Scholar
• Heskamp MS, Schramm GAK. Efficacy of the low dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: Physical and emotional benefits. Contraception 2010;81:49–56.
   PubMed Web of Science ®Google Scholar
• Panzer C, Guay A, Goldstein I. Do oral contraceptives produce irreversible effects on women's sexuality?: A reply. J Sex Med 2006;3:568–70.
   Web of Science ®Google Scholar
• Bancroft J, Hammond G, Graham C. Do oral contraceptives produce irreversible effects on women's sexuality?J Sex Med 2006;3:567.
   PubMed Web of Science ®Google Scholar
• Asunción M, Calvo RM, San Millán JL, . A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–2438.
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Hahn S, Kowalsky D, . Quality of life, psychosocial well-being and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:5801–7.
   PubMed Web of Science ®Google Scholar
• Weiner CL, Primeau M, Ehrmann DA. Androgen and mood dysfunction in women: Comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;66:356–62.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein GD, Simon JA, . Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New Engl J Med 2000;343: 682–8.
   PubMed Web of Science ®Google Scholar
• Persky H, Dreisbach L, Miller W, . The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom Med 1982;44:305–19.
   PubMed Web of Science ®Google Scholar
• Meston CM, Buss DM. Why humans have sex. Arch Sex Behav 2007;36:477–507.
   PubMed Web of Science ®Google Scholar
• Stuckey BGA. Female sexual function and dysfunction in the reproductive years: The influence of endogenous and exogenous sex hormones. J Sex Med 2008;5:2282–90.
   PubMed Web of Science ®Google Scholar